1. Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose death counts.: National Center for Health Statistics.; 2021 [Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation.
2. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2021. Contract No.: HHS Publication No. PEP21-07-01-003, NSDUH Series H-56.
3. Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. Admission Practices and cost of Care for Opioid Use Disorder at Residential Addiction Treatment Programs in the US. Health Aff (Millwood). 2021;40(2):317–25.
4. Harris AH, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Rubinsky AD, et al. Predictive validity of two process-of-care quality measures for residential substance use disorder treatment. Addict Sci Clin Pract. 2015;10:22.
5. Stewart MT, O’Brien PL, Shields MC, White MC, Mulvaney-Day N. State Residential Treatment for Behavioral Health Conditions: Regulation and Policy Environmental Scan: U.S. Department of Health and Human Services, Assistant Secretary for Planning and Evaluation Disability, Aging and Long-Term Care Policy; 2019 [Available from: https://aspe.hhs.gov/system/files/pdf/262961/BehHeaConLR.pdf.